ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)
The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients hospitalized for COVID-19 include hastening recovery and preventing progression to…
- Investigator
- Nicole M Iovine
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Adaptive COVID-19 Treatment Trial (ACTT)
This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in…
- Investigator
- Nicole M Iovine
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All